Lexaria Bioscience Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $7.8M
Liabilities Breakdown FY2022
Total Liabilities: $201.4K
Asset Breakdown
Total Assets: $7.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.8M | 74.2% |
| Accounts Receivable | $201.8K | 2.6% |
| Inventory | $38.4K | 0.5% |
| Property, Plant & Equipment | $315.5K | 4.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.5M | 18.7% |
Liabilities Breakdown
Total Liabilities: $201.4K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $151.4K | 75.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $50.0K | 24.8% |